Shanghai Nianxing Industrial Co., Ltd
China
Product Name: JAK2/TYK2-IN-1
Price: Check
Purity: 98.0%
Stocking Period: 10 Day
Contact: Yang
Email: sales@echemcloud.com

DC Chemicals Limited
China
Product Name: JAK2/TYK2-IN-1
Price: $Inquiry/100mg $Inquiry/250mg $Inquiry/1g
Purity: 98.0%
Stocking Period: 3 Day
Contact: Tony Cao
Email: sales@dcchemicals.com

2613434-12-9

2613434-12-9 structure

2613434-12-9 structure

Name: JAK2/TYK2-IN-1
Chemical Name: JAK2/TYK2-IN-1
CAS Number: 2613434-12-9
Molecular Formula: C₁₉H₁₃F₄N₇O₂S
Molecular Weight: 479.41
Create Date: 2022-05-20 11:42:58
Modify Date: 2025-08-26 22:28:13
JAK2/TYK2-IN-2 is a potent and selective TYK2 inhibitor with IC50 values of 9 and 157 nM for TYK2 and JAK2, respectively. JAK2/TYK2-IN-2 has anti-inflammatory activity[1].

Name	JAK2/TYK2-IN-1

Description	JAK2/TYK2-IN-2 is a potent and selective TYK2 inhibitor with IC50 values of 9 and 157 nM for TYK2 and JAK2, respectively. JAK2/TYK2-IN-2 has anti-inflammatory activity[1].
Related Catalog	Signaling Pathways >> JAK/STAT Signaling >> JAK Signaling Pathways >> Epigenetics >> JAK Signaling Pathways >> Stem Cell/Wnt >> JAK Research Areas >> Inflammation/Immunology
Target	Tyk2:9 nM (IC50) JAK2:157 nM (IC50)
In Vitro	JAK2/TYK2-IN-2 (compound 14l; 0-10000 nM) inhibits the phosphorylation of STAT in vitro[1]. Western Blot Analysis[1] Cell Line: TF-1, H9, TF-1, THP-1 cells Concentration: 0-10000 nM Incubation Time: Result: After stimulation with IL-6 and IFN-α at a concentration of 100 to 5000 nM, JAK2/TYK2-IN-2 reduced JAK1/JAK2/TYK2 and JAK1/TYK2-dependent signal transduction in a dose-dependent manner and remarkably reduced IFN-α-induced phosphorylation at 10 000 nM.
In Vivo	JAK2/TYK2-IN-2 (10 and 20 mg/kg; oral administration; twice a day for 6 consecutive days) exhibits anti-inflammatory activity in a dose-dependent manner[1]. JAK2/TYK2-IN-2 (5, 20 mg/kg; oral administration; twice a day for 12 days) leads to a low oral bioavailability[1].Pharmacokinetic Parameters of JAK1/TYK2-IN-2 in Male Sprague-Dawley rats[1] PK parameters iv PK parameters p.o. AUC(0-t) (μg/Lh) 29.00 AUC(0-t) (μg/Lh) 13.89 MRT(0-t) (h) 4.98 MRT(0-t) (h) 2.76 t1/2 (h) 5.95 t1/2 (h) 3.64 Cl (L/min/kg) 1.58 Cl (L/min/kg) 20.55 Vss (L/kg) 985.41 Vss (L/kg) 6564.28 Cmax (μg/L) 48.55 Cmax (μg/L) 8.00 Tmax (h) 1.00 F 11.96% Animal Model: Six-eight week old male C57BL/6 mice, 20-22 g (acute mice colitis model)[1] Dosage: 10, 20 mg/kg (dissolved in 5% EtOH, 1% Propylene glycol, 0.5% Tween 80 and 92.5% physiological saline) Administration: Oral administration, twice a day 6 consecutive days Result: Exhibited anti-inflammatory activity and have a good therapeutic effect on inflammatory bowel disease (IBD) in a dose-dependent manner.
References	[1]. Zhang C, et al. Discovery of 3-(4-(2-((1H-Indol-5-yl) amino)-5-fluoropyrimidin-4-yl)-1H-pyrazol-1-yl) propanenitrile Derivatives as Selective TYK2 Inhibitors for the Treatment of Inflammatory Bowel Disease. J Med Chem. 2021; 64(4):1966-1988.

Molecular Formula	C₁₉H₁₃F₄N₇O₂S
Molecular Weight	479.41

The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.